Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.42
Price to sales ratio
207.27

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4626
PLUR
Pluri Inc. - Common Stock
1.81 USD+3.43%-2.69%-19.91%-52.64%19.53 M USD
4627
TVGN
Tevogen Bio Holdings Inc. - Common Stock
4.66 USD-2.51%-14.96%-51.20%+278.86%19.51 M USD
4638
LPCN
Lipocine Inc. - Common Stock
2.32 USD-1.69%-5.69%-0.43%-20.00%19.13 M USD
4645
NCEL
NewcelX Ltd. - Ordinary Shares
3.77 USD-4.07%-12.73%+16.00%-25.79%18.09 M USD

Frequently asked questions about Neuphoria Therapeutics Inc. - Common Stock

What is the Neuphoria Therapeutics Inc. - Common Stock stock price today?

The current price of Neuphoria Therapeutics Inc. - Common Stock (NEUP) is 3.52. Over the past 24 hours, the stock has changed by 0.00%. Follow the NEUP chart for real-time price dynamics.

What is the stock ticker of Neuphoria Therapeutics Inc. - Common Stock?

Neuphoria Therapeutics Inc. - Common Stock trades under the ticker NEUP. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Neuphoria Therapeutics Inc. - Common Stock stock going up?

NEUP has changed by +1.73% over the last week, -18.33% over the last month, and -52.50% over the last year. Review the chart to see whether the current move is part of a broader trend.

How many employees does Neuphoria Therapeutics Inc. - Common Stock have?

As of the latest available data, Neuphoria Therapeutics Inc. - Common Stock has 8 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Neuphoria Therapeutics Inc. - Common Stock stock?

You can buy Neuphoria Therapeutics Inc. - Common Stock (NEUP) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Neuphoria Therapeutics Inc. - Common Stock stock?

Investing in Neuphoria Therapeutics Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NEUP chart and related analysis on metatrader.com as part of your research.